Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States

Rates of HCC treatment in the United States, including curative treatment rates among patients detected at an early stage, are disappointingly low. Future efforts should focus on identifying appropriate intervention targets to increase treatment rates and reduce socio-demographic disparities.